| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/28/2004 | US6797483 Polypeptide and DNA thereof |
| 09/28/2004 | US6797473 Methods and compounds for modulating male fertility |
| 09/28/2004 | US6797472 For making treatment decisions for patients suffering from asthma and chronic obstructive pulmonary diseases (copd); pharmacogenomics |
| 09/28/2004 | US6797467 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 09/28/2004 | US6797466 Complete genome sequence of the methanogenic archaeon, Methanococcus jannaschii |
| 09/28/2004 | US6797288 Vegetable protein for use as gelling agent in food preparation |
| 09/28/2004 | US6797274 Compounds |
| 09/28/2004 | US6797273 Neisseria meningitidis antigen |
| 09/28/2004 | US6797272 Enhanced immunogenicity using leukotoxin chimeras |
| 09/28/2004 | US6797271 Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides |
| 09/28/2004 | US6797270 Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy |
| 09/28/2004 | US6797269 Mesenchymal stem cells as immunosuppressants |
| 09/28/2004 | US6797265 Therapy for metabolism disorders; gene therapy |
| 09/28/2004 | US6797263 Compositions and methods for achieving immune suppression |
| 09/28/2004 | CA2458081A1 Peptide antioxidants from soy protein |
| 09/28/2004 | CA2298414C Method for preventing and treating hearing loss using a neurturin protein product |
| 09/28/2004 | CA2191088C Copolymer-1 improvements in compositions of copolymers |
| 09/28/2004 | CA2167268C Anti-angiogenic compositions and methods of use |
| 09/28/2004 | CA2162557C Conserved motif of hepatitis c virus e2/ns1 region |
| 09/28/2004 | CA2147838C The pct-65 serotonin receptor |
| 09/26/2004 | CA2424255A1 Immunotoxins |
| 09/24/2004 | WO2005111058A1 Intracellular delivery of osteoinductive proteins and peptides |
| 09/24/2004 | CA2517496A1 Intracellular delivery of osteoinductive proteins and peptides |
| 09/23/2004 | WO2004081533A2 Vault and vault-like carrier molecules |
| 09/23/2004 | WO2004081515A2 Purification process for bacterial cytolysin |
| 09/23/2004 | WO2004081233A1 Diagnostic and prognostic compounds and method |
| 09/23/2004 | WO2004081231A1 Screening assays for targets and drugs useful in treatment and prevention of lipid metabolism disorders |
| 09/23/2004 | WO2004081217A2 Method for increasing resistance against stress factors in plants |
| 09/23/2004 | WO2004081214A1 Papillosin antimicrobial peptide, a gene for coding said peptide, a vector, a transformed organism and a compound containing said organism |
| 09/23/2004 | WO2004081210A1 GENE Lhd4 CONTROLLING PLANT FLOWERING AND UTILIZATION THEREOF |
| 09/23/2004 | WO2004081209A1 Genes controlling plant cell wall formation |
| 09/23/2004 | WO2004081204A1 Plant and plant cell having been modified in cell multiplication and development/differentiation |
| 09/23/2004 | WO2004081203A1 Extraction and use of collagen extracted from either a sea mammal or a bony fish |
| 09/23/2004 | WO2004081202A1 METHOD FOR PRODUCING TARGET PROTEINS BY DELETING OR AMPLIFYING ibpA AND/OR ibpB GENE CODING FOR INCLUSION BODY-ASSOCIATED PROTEINS |
| 09/23/2004 | WO2004081200A2 Phospholipid scramblase 3 |
| 09/23/2004 | WO2004081199A2 Novel compositions and methods for the treatment of immune related disease |
| 09/23/2004 | WO2004081197A2 Immune response associated proteins |
| 09/23/2004 | WO2004081190A2 Uses of il-23 agonists and antagonists; related reagents |
| 09/23/2004 | WO2004081189A2 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and organisms |
| 09/23/2004 | WO2004081188A2 Non-toxic membrane-translocating peptides |
| 09/23/2004 | WO2004081187A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 09/23/2004 | WO2004081177A2 Intracellular signaling pathways in diabetic subjects |
| 09/23/2004 | WO2004081174A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 09/23/2004 | WO2004081170A2 Progestin receptor-like protein |
| 09/23/2004 | WO2004081167A2 Expression vectors comprising the mcmv ie2 promoter |
| 09/23/2004 | WO2004081052A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | WO2004081045A2 Vaccine related to modified apolipoprotein c-iii |
| 09/23/2004 | WO2004081044A1 Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (par1) |
| 09/23/2004 | WO2004081043A2 Baff mutants with at least one amino acid substitution and methods of their production |
| 09/23/2004 | WO2004081042A2 Identification of pain-relevant genes of a snsr family (specific sensory neurone receptors) |
| 09/23/2004 | WO2004081041A1 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof |
| 09/23/2004 | WO2004081040A2 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications |
| 09/23/2004 | WO2004081039A1 Novel protein and its dna |
| 09/23/2004 | WO2004081038A1 Purification of peptides from colostrum |
| 09/23/2004 | WO2004081037A1 Inhibitors of extracellular hsp90 |
| 09/23/2004 | WO2004081036A1 Peptidic antibiotic |
| 09/23/2004 | WO2004081035A1 Peptide fragment of lyve-1 and antibody against the same |
| 09/23/2004 | WO2004081032A2 Novel litaf binding site peptides and methods of using the same |
| 09/23/2004 | WO2004081031A2 Thiol-mediated drug attachment to targeting peptides |
| 09/23/2004 | WO2004081030A2 Peptides selectively lethal to malignant and transformed mammalian cells |
| 09/23/2004 | WO2004081028A2 Allergen peptide fragments and use thereof |
| 09/23/2004 | WO2004081024A2 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 09/23/2004 | WO2004080575A1 Use of recombinant albumin in dialysis after liver failure |
| 09/23/2004 | WO2004080485A1 Preventive/remedy for diseases in upper digestive tract |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080425A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080406A2 Therapeutic compositions |
| 09/23/2004 | WO2004080405A2 Igf-binding protein-derived peptide or small molecule |
| 09/23/2004 | WO2004080404A2 Il-2 transmembrane constructs |
| 09/23/2004 | WO2004080403A2 Influenza virus vaccine |
| 09/23/2004 | WO2004080375A2 Vaccine therapy of atherosclerosis |
| 09/23/2004 | WO2004080148A2 Novel nucleic acids and polypeptides |
| 09/23/2004 | WO2004071464A8 Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells |
| 09/23/2004 | WO2004069993A3 Non-touch zona pellucida microdrilling of a single - cell embryo with a 1.48 um laser beam for introduction of retrovirus |
| 09/23/2004 | WO2004067704A3 Freeze-dried fibrin matrices and methods for preparation thereof |
| 09/23/2004 | WO2004066914A3 Variant integrin polypeptides and uses thereof |
| 09/23/2004 | WO2004063354A3 Compositions and methods for characterizing and regulating wnt pathways |
| 09/23/2004 | WO2004060052A3 Transgenic mice expressing human cd20 and/or cd16 |
| 09/23/2004 | WO2004058963A3 A novel gene osisap1 of rice confers tolerance to stresses and a method thereof |
| 09/23/2004 | WO2004056996A3 The escherichia coli csrc gene and uses thereof for biofilm modulation |
| 09/23/2004 | WO2004056867A3 Ion channel for testing pharmacological active compounds |
| 09/23/2004 | WO2004056853A3 An immunomodulatory protein derived from trypanosomes and uses thereof |
| 09/23/2004 | WO2004055052A3 Nucleic acid sequences for use as biomarker for damage to the intestinal epithilum |
| 09/23/2004 | WO2004050703A8 Splice variant of the human pituitary growth hormone |
| 09/23/2004 | WO2004044587A3 Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5) |
| 09/23/2004 | WO2004043404A3 Process for designing inhibitors of influenza virus non-structural protein 1 |
| 09/23/2004 | WO2004042345A3 Bacterial small-molecule three-hybrid system |
| 09/23/2004 | WO2004037858A3 Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof |
| 09/23/2004 | WO2004037847A3 Hiv envelope-cd4 complexes and hybrids |
| 09/23/2004 | WO2004035082A3 Proteins involved in the regulation of energy homeostasis |
| 09/23/2004 | WO2004031415A3 Methods and compositions for rapid development of screening assays nuclear receptors |
| 09/23/2004 | WO2004031349A3 Polynucleotides and polypeptides in plants |
| 09/23/2004 | WO2004031229A3 P53 binding polypeptide |
| 09/23/2004 | WO2004029575A3 Methods for diagnosing htlv-i-mediated diseases |
| 09/23/2004 | WO2004028444A3 Parathyroid hormone antagonists and uses thereof |
| 09/23/2004 | WO2004027092A3 Dna chips used for bioprocess control |
| 09/23/2004 | WO2004024877A3 Human kininogen d3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 09/23/2004 | WO2004023973A3 Molecules for diagnostics and therapeutics |
| 09/23/2004 | WO2004020593A3 Immune response associated proteins |